作者
Darron R Brown, Susanne K Kjaer, Kristján Sigurdsson, Ole-Erik Iversen, Mauricio Hernandez-Avila, Cosette M Wheeler, Gonzalo Perez, Laura A Koutsky, Eng Hseon Tay, Patricía Garcia, Kevin A Ault, Suzanne M Garland, Sepp Leodolter, Sven-Eric Olsson, Grace WK Tang, Daron G Ferris, Jorma Paavonen, Marc Steben, F Xavier Bosch, Joakim Dillner, Elmar A Joura, Robert J Kurman, Slawomir Majewski, Nubia Muñoz, Evan R Myers, Luisa L Villa, Frank J Taddeo, Christine Roberts, Amha Tadesse, Janine Bryan, Lisa C Lupinacci, Katherine ED Giacoletti, Heather L Sings, Margaret James, Teresa M Hesley, Eliav Barr
发表日期
2009/4/1
期刊
The Journal of infectious diseases
卷号
199
期号
7
页码范围
926-935
出版商
The University of Chicago Press
简介
BackgroundHuman papillomavirus (HPV)–6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18–related cervical intraepithelial neoplasia (CIN) 1–3 or adenocarcinoma in situ (AIS). Here, its impact on CIN1–3/AIS associated with nonvaccine oncogenic HPV types was evaluated
MethodsWe enrolled 17,622 women aged 16–26 years. All underwent cervicovaginal sampling and Pap testing at regular intervals for up to 4 years. HPV genotying was performed for biopsy samples, and histological diagnoses were determined by a pathology panel. Analyses were conducted among subjects who were negative for 14 HPV types on day 1. Prespecified analyses included infection of ⩾6 months’ duration and CIN1–3/AIS due to the 2 and 5 most common HPV types in cervical cancer after HPV types 16 and 18, as well as all tested nonvaccine types
ResultsVaccination reduced the incidence …
引用总数
200920102011201220132014201520162017201820192020202120222023202441808488735652403228292128112014